In a letter distributed April 30th, Dean of Medicine Edward Miller, MD, announced a new policy “designed to reorient the way we work with pharmaceutical and medical devices industries to support independent decision-making and transparency.” The changes limit some interactions with commercial entities and clarify the terms of permitted collaborations. The policy will take effect on July 1, 2009.
The text of the new policy is accessible online at http://www.hopkinsmedicine.org/Research/OPC/
Questions may be directed to the Office of Policy Coordination at policy@jhmi.edu





